Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until February 1, 2026

Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article.

Available until February 1, 2026

Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another. The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment. However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic.